KYMR: kymeratx.com Net earnings per share for the last 12 months

Symbol and logo of brand Kymera (KYMR)

How do geopolitical risks impact the profitability of Kymera Therapeutics (KYMR)? The EPS TTM history provides the answer, where the -3.62 mark records this metric. Business growth relies on AI platforms for cancer treatment, although medicine requires manual oversight. The strategy's effectiveness is confirmed by partner confidence and management's strict adherence to the clinical validation plan.

KYMR (Kymera Therapeutics) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/18/2026

Analytical breakdowns for Kymera Therapeutics

- share price and expert price forecast:
- market capitalization information:
Basic company analysis:Kymera Therapeutics - KYMR
Manufactured products of Kymera Therapeutics, Inc.

This indicator measures the company's total profit allocated per ordinary share over a rolling year, which offsets quarterly volatility and allows for an assessment of the business's actual profitability. By analyzing the rolling net income per share, an investor can see how advances from pharma behemoths for protein degradation research are transforming into the financial stability of Kymera Therapeutics (KYMR).

Who Kymera Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|IDYA: Earnings per share for the last four quarters|ELVN (Enliven Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oricpharma.com|Earnings per share for the last twelve months Relay Therapeutics, Inc. (RLAY)|NRIX (Nurix Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences Inc)|Net earnings per share for the trailing year Verastem Inc|Monte Rosa Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Therapeutics, Inc.|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)